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http:WHAT THIS PAPER ADDS
The key ﬁndings of this study are that 5 year survival after elective infrarenal AAA repair is 69% and that this
value has not improved over the period 1969e2011. A larger aneurysm diameter at the time of surgery was
associated with poorer 5 year survival. This 5 year survival ﬁgure is disappointingly poor; patients diagnosed with
a Dukes B colorectal cancer can expect better 5 year survival. More needs to be done to address the shortfall in
survival to ensure that patients who can now reasonably expect to survive major aortic surgery live long enough
to justify what remains a signiﬁcant intervention.Background: Improved critical care, pre-operative optimization, and the advent of endovascular surgery (EVAR)
have improved 30 day mortality for elective abdominal aortic aneurysm (AAA) repair. It remains unknown
whether this has translated into improvements in long-term survival, particularly because these factors have also
encouraged the treatment of older patients with greater comorbidity. The aim of this study was to quantify how
5 year survival after elective AAA repair has changed over time.
Methods: A systematic review was performed identifying studies reporting 5 year survival after elective
infrarenal AAA repair. An electronic search of the Embase and Medline databases was conducted to January
2014. Thirty-six studies, 60 study arms, and 107,814 patients were identiﬁed. Meta-analyses were conducted to
determine 5 year survival and to report whether 5 year survival changed over time.
Results: Five-year survival was 69% (95% CI 67 to 71%, I2 ¼ 87%). Meta-regression on study midpoint showed no
improvement in 5 year survival over the period 1969e2011 (log OR 0.001, 95% CI 0.014e0.012). Larger
average aneurysm diameter was associated with poorer 5 year survival (adjusted log OR 0.058, 95% CI 0.095
to 0.021, I2 ¼ 85%). Older average patient age at surgery was associated with poorer 5 year survival (adjusted
log OR 0.118, 95% CI 0.142 to 0.094, I2 ¼ 70%). After adjusting for average patient age, an improvement in
5 year survival over the period that these data spanned was obtained (adjusted log OR 0.027, 95% CI 0.012 to
0.042).
Conclusion: Five-year survival remains poor after elective AAA repair despite advances in short-term outcomes
and is associated with AAA diameter and patient age at the time of surgery. Age-adjusted survival appears to
have improved; however, this cohort as a whole continues to have poor long-term survival. Research in this ﬁeld
should attempt to improve the life expectancy of patients with repaired AAA and to optimise patient selection.
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Over recent decades, there has been a consistent
improvement in the short-term mortality associated with
elective repair of infrarenal aortic aneurysms (AAA). These
improvements have followed general developments in
surgical technique and peri-operative procedures,1 the
advent of endovascular surgery,2e7 improvements in critical
care and vascular anaesthesia, and the centralization of
aortic surgery to specialist teams with high operative
caseload.
The decision to repair an AAA requires consideration of
the risk of rupture without surgery, the peri-operative risk
of death, and the patient’s overall life expectancy; balanced
with the patient’s own preference. As the aim of AAA repair
is to prolong life through the prevention of rupture, surgery
should only be performed if the risk of rupture without
surgery outweighs the peri-operative risk of surgery itself, in
patients whose life expectancy is long enough to result in
long-term beneﬁt. It is therefore perhaps unsurprising that
short-term operative mortality has been the primary focus
of most outcomes research reporting the results of AAA
repair. However, longer-term mortality continues to be
concerning in the years that follow surgery,8 as patientsFigure 1. PRISMwith AAA have considerable cardiovascular risk factors
compared with the wider population.9,10
It remains unknown whether improvements in the peri-
operative safety of AAA repair have translated to
improved 5 year survival following surgery. Long-term sur-
vival critically inﬂuences the cost-effectiveness of AAA
repair,2 and is a key measure to justify surgical intervention
at a population level. Understanding trends in published
results will clarify whether long-term survival is an appro-
priate therapeutic target for further research. The aim of
this study was to quantitatively summarise the evidence for
5 year survival after elective infrarenal AAA repair to assess
whether improvements in peri-operative practice have
translated into better long-term mortality over time.METHODS
An electronic search of all English-language literature was
performed using the Embase and Medline databases,
covering the years 1950e2013, in accordance with
Preferred Items for Reporting of Systematic Reviews and
Meta Analyses (PRISMA) guidelines (Fig. 1). The free-text
search terms “abdom*,” “aortic aneurysm,” “abdo-
m*aort*,” “AAA,” “surger*,” “surgical*,” “repair*,” “surviv*,”A diagram.
322 S.S. Bahia et al.“mortal*,” “electiv*,” “elect*,” “emergenc*,” and MeSH/
Emtree terms “aortic aneurysm, abdominal, surgical pro-
cedures, operative, mortality, survival rate, disease-free
survival, surgical procedures, elective,” [MeSH] and
“abdominal aorta aneurysm, surgery, aorta surgery,
abdominal surgery, aneurysm surgery, survival, disease free
survival, failure free survival, long term survival, post
treatment survival, survival rate, survival time, mortality,
surgical mortality, elective surgery,” [Emtree] were used in
combination with the Boolean operators AND or OR and
NOT (Appendix I). RefWorks software (RefWorks, Bethesda,
MD, USA) was used to de-duplicate the electronic search
results.
Grey literature and reference lists from relevant papers
were reviewed to identify other studies that may have
contained relevant data. The inclusion criteria for this meta-
analysis comprised studies reporting 4 year, 5 year, or 6 year
survival after elective repair of an infrarenal aortic aneu-
rysm, using a principled statistical technique to account for
loss to follow up, other censoring of data, or varying
recruitment over time. Studies were excluded if they did
not report the “numbers at risk” at 5 years or at both 4 and
6 years. Abstracts of citations identiﬁed from the literature
search were reviewed by two of the authors (SSB and BOP),
who then independently extracted all relevant data. Any
disagreements were resolved by consensus agreement; this
was overseen and arbitrated when necessary by another of
the authors (AK).
Studies were also excluded where data for patients with
AAA were not separable from data for patients with other
aneurysm morphologies (juxtarenal, suprarenal, thoraco-
abdominal) or occlusive aortic disease, if no date range
for the study was given, if emergent and elective survival
was not reported separately, and if speciﬁc age or comor-
bidity patient subgroups were reported without survival
data for the patient group as a whole.
Data were extracted regarding each study’s country of
origin, study timeframe and midpoint, medical therapies
such as antiplatelet and statin therapy and comorbidity data
such as known ischaemic heart disease, diabetes mellitus,
or smoking status. The mean/median aneurysm diameter
for patients undergoing surgery was extracted where
described.
A random effects meta-analysis was conducted to
quantify the 5 year survival of patients undergoing elective
AAA repair. Meta-regression was performed to assess
whether 5 year survival was associated with study midpoint
or aneurysm diameter at the time of surgery.
Statistical analyses
The meta-analysis to quantify 5 year survival was performed
using a random effects model (dictated by the large degree
of heterogeneity among the studies included in the anal-
ysis) as per DerSimonian and Laird on the log odds of sur-
vival outcome scale.11 All meta-analyses and meta-
regressions treated the arm level data as independentand so any correlation resulting from arms from the same
study was ignored in analysis. This was an acknowledged
limitation of the statistical modelling. Within-study vari-
ances were calculated using a conservative sample size
(number at risk at 5 years/survival probability) to produce
large within study variances such that censoring had the
most effect in increasing the uncertainty of the study arm
estimates. For studies that only provided 4 year and 6 year
survival values, and number of patients at risk, averaging
the 4 year and 6 year values derived the 5 year survival
value.
A random effects meta-regression analysis was carried
out to assess the change, if any, over the timescale that
these studies covered using moments estimator method-
ology. This analysis used the same outcome data as in the
meta-analysis for survival; and study mid-date (in years) was
used as the only covariate. This analysis resulted in a log-
odds ratio of survival associated with a 1 year change in
study mid-date, where a positive log-odds ratio indicated
that the probability of 5 year survival after AAA repair
increased over time.
A second random effects meta-regression analysis was
conducted to evaluate the effect of aneurysm diameter
on 5 year survival, while adjusting for the effect of time.
This analysis used study mid-date and the mean diameter
(in mm) as covariates, so that an adjusted (for time) log-
odds ratio associated with a 1 mm increase in mean
diameter was obtained. Here a positive log-odds ratio
indicated that the survival probability increased as mean
diameter increased. Finally, a third random effects meta-
regression was conducted using mid-date and average
patient age (in years), so that an adjusted (for time) log-
odds ratio associated with a 1 year increase in age was
obtained. Here a positive log-odds ratio indicated that
the survival probability increased as age increased. All
analyses were performed in “R” using the metafor
package.
RESULTS
Thirty-six studies reported 107,814 patients from 14
different countries between 1969 and 2011 and contributed
to survival meta-analysis and a meta-regression of the
relationship between 5 year survival and study mid-point
(PRISMA diagram and Table 1). Of these, 18 studies con-
sisting of 13,281 patients contributed to the meta-
regression of the relationship between aneurysm diam-
eter at the time of surgery and subsequent 5 year survival
(Table 2).
Information to describe comorbid conditions and
medication was limited; eight studies reported the pro-
portion of patients prescribed statin or antiplatelet agents
but with limited data on dose regimens. Twenty-nine of 36
studies reported relevant comorbidity but with poor pre-
cision in classiﬁcation (Table 3). There was a wide range of
prevalence of diabetes (5.4e22.7%), dyslipidaemia (11.0e
56.2%), ischaemic heart disease (25.0e82.7%), and
Table 1. Studies contributing to overall 5 year survival.
Country providing data Number of studies Number of patients First author or study name
US 11 92,957 Bernstein,14 Brewster,18 Conrad,21 De Martino,45
Egorova,24 Evans,25 Hallett,28 Lederle,5,31 Lifeline
Registry,32 Whittemore43
UK 6 2853 Bryce,19 Stonebridge,38 Taylor,39 UK SAT,40 UK
EVAR-1,26 UK EVAR-227
France 3 1581 Bartoli,12 Koskas,30 Steinmetz,37
Holland 3 950 Bos,16 De Bruin,3 Verhoeven,41
Australia 2 1264 Boult,17 May33
Japan 2 730 Mukai,35 Yasuhara44
Italy 2 1169 Cao,20 Coppi22
Austria 1 895 Sahal36
Belgium 1 143 Mertens34
Finland 1 358 Biancari15
Germany 1 205 Hinterseher29
Turkey 1 167 Bayazit13
Sweden 1 3831 Wahlgren42
Switzerland 1 711 Diehm23
TOTAL 36 107,814
Long-term Survival After AAA Repair 323hypertension (24.0e83.7%) between studies, reﬂecting
considerable variation in reporting standards. The distri-
bution between Type 1 and Type 2 diabetes was not re-
ported. Fifteen of these 29 studies reported the
percentage of active smokers (16.0e82.9%), with six of
the 29 studies reporting the percentage of ex-smokers
(48.0e77.2%).
Of the eight studies reporting concomitant medication,
the range of patients on antiplatelet agents was 40.5e
72.6% and 14.8e69.1% were reported as taking a statin.
Dosage ranges and speciﬁc drug names were not provided.
There was very limited reporting on cause of death. Mean
age and study characteristics for all studies included in
these analyses are also reported (Tables 4 and 5).Table 2. Studies contributing to aneurysm diameter analysis.
First author or
study name
Year of
publication
Number of
patients
Mean aneurysm
diameter (mm)
Bernstein14 1988 123 58
Biancari15 2003 358 50
Bos16 2008 234 60.9
Brewster18 2006 873 56.8
Cao20 2004 1119 54.1
Conrad21 2007 540 58.9
Coppi22 2008 50 58
De Martino45 2013 2367 53.6
Diehm23 2007 711 58.2
EVAR-126 2010 1252 64.5
EVAR-227 2010 197 68
Lederle5 2012 881 57
Lifeline Registry32 2005 2577 55.8
May33 1998 303 54.9
Mertens34 2011 143 57.5
Steinmetz37 2010 625 57.2
UK SAT40 2002 563 46.3
Verhoeven41 2011 365 61
TOTAL 13,281 Range 46.3e68Five-year survival after elective AAA repair
Thirty-six studies consisting of 60 study arms and a total of
107,814 patients,3,5,12e45 covering the period 1969 to 2011
(Table 1) contributed to the meta-analysis of 5 year survival
after AAA repair.
Of the patients, 80.3% (86,475/107,691) were male and
49.9% (53,490/107,251) underwent open repair. The pooled
estimate for 5 year survival after elective AAA repair was
69% (95% CI 67 to 71%, I2 ¼ 87%; Fig. 2).Trend over time for 5 year survival after AAA repair
Meta-regression conducted to evaluate the survival trend
over time demonstrated that there was no signiﬁcant
improvement (or deterioration) in 5 year survival over the
period that these data span (log OR 0.001, 95% CI 0.014
to 0.012, I2 ¼ 87%; Fig. 3).Aneurysm diameter and 5 year survival after AAA repair
Eighteen studies, consisting of 29 study arms, provided
mean aneurysm diameter data and were included in this
analysis.5,14e16,18,20e23,26,27,32e34,37,40,41,45 This comprised
13,281 patients with a mean aneurysm diameter range of
46.3 mm to 68 mm, from data covering the period 1978e
2011 (Table 2).
Meta-regression demonstrated that larger aneurysm
diameter at the time of surgery was associated with poorer
5 year survival (adjusted log OR 0.058, 95% CI 0.095
to 0.021, I2 ¼ 85%). There was no evidence of signiﬁcant
improvement (or deterioration) in 5 year survival (adjusted
log OR 0.015, 95% CI 0.020 to 0.050).
Visualizing regression analyses for more than a single
covariate is difﬁcult, and here the effect of time was small
and statistically insigniﬁcant, so in Fig. 4 a plot is shown for
a meta-regression where the only covariate is the mean
diameter. The resulting unadjusted log OR (0.052, 95%
Table 3. Comorbidity and medication.
Study N at start Diab (%) Dyslipid. (%) IHDa (%) HTN (%) Ex-smoker (%) Smoker (%) AntiPLT (%) Statin (%)
Lederle et al. (OVER)5 881 22.7 e 40.7 76.9 54.2 41.2 59.2 e
Conrad et al.21 540 8.0 e 25.0 68.0 48.0 16.0 e e
EVAR-126 1252 10.4 e 42.4 e 69.0 21.6 53.0 35.5
De Bruin et al.3 351 11.4 49.8 43.8 56.7 e 59.6 40.5 39.6
Brewster et al.18 873 12.4 43.5 57.2 73.4 e 65.1 e e
Lederle et al.31 569 9.7 e 43.6 57.8 52.8 41.4 e e
Wahlgren et al.42 3831 9.3 41.7 54.6 56.9 e 46.1 e 14.8
EVAR-227 197 15.4 e 67.0 e 77.2 16.8 58.2 41.8
Bartoli et al.12 162 80.8 48.8 37.0 73.0 e 75.9 e e
Bayazit et al.13 167 5.4 e 50.7 65.0 e e e e
Bos et al.16 234 14.5 35.0 48.7 57.3 e e e e
Bryce et al.19 106 8.0 14.0 24.0 67.0 52.0 33.0 59.0 62.0
Cao et al.20 1119 8.0 32.5 41.5 66.0 e e e e
Coppi et al.22 50 10.0 14.0 40.0 46.0 e 26.0 e e
De Martino et al.45 2367 18.7 e 33.8 83.7 e e 72.6 69.1
Diehm et al.23 711 15.0 51.3 45.0 80.6 e e 45.6 42.6
Koskas et al.30 794 9.2 37.3 42.8 47.6 e e e e
Hallett et al.28 130 8.0 e 42.0 47.0 e 44.0 e e
May et al.33 303 8.0 e 51.4 31.4 e e e e
Sahal et al.36 895 15.8 e e 73.3 e e e e
Steinmetz et al.37 626 14.1 56.2 49.3 72.8 e e e e
Evans et al.25 147 11.0 e 38.0 44.0 e 48.0 e e
Whittemore et al.43 110 6.0 e 44.0 24.0 e e e e
Yasuhara et al.44 338 8.6 e 23.3 55.0 e e e e
Lifeline Registry32 2577 12.4 e 82.7 64.0 e e e e
Biancari et al.15 358 9.7 14.4 50.1 39.0 e 31.5 e e
Egorova et al.24 84,640 15.1 39.3 52.0 71.8 e e e e
Bernstein et al.14 123 8.1 e e 45.9 e 82.9 e e
Mukai et al.35 392 11.0 11.0 35.0 69.0 e e e e
Range 5.4e22.7 11.0e56.2 25.0e82.7 24.0e83.7 48.0e77.2 16.0e82.9 40.5e72.6 14.8e69.1
a Ischaemic heart disease was reported variously from “previous myocardial infarction” to “previous coronary artery intervention” to
“known ischaemic heart disease.”
324 S.S. Bahia et al.CI 0.088 to 0.017, I2 ¼ 86%) is very similar to the
adjusted one.Patient age and 5 year survival after AAA repair
Twenty-four studies, consisting of 40 study arms, provided
mean age data and were included in this analysis.3,5,12,13,15e
17,21,23,24,26,27,29,31,32,35,37e42,44,45 This comprised 103,021
patients with a mean age range of 63 years to 78.5 years,
from data covering the period 1978e2011 (Table 5).
Meta-regression demonstrated that older patient age at
the time of surgery was associated with poorer 5 year
survival (adjusted log OR 0.118, 95% CI 0.142
to 0.094, I2 ¼ 70%). Having adjusted for mean patient
age in this meta-regression, there was evidence of signif-
icant improvement in 5 year survival over the period that
these data span (adjusted log OR 0.027, 95% CI 0.012 to
0.042). As both estimated effects in this meta-regression
are quite large and statistically signiﬁcant it is difﬁcult to
visualize this regression model using two dimensions. This
meta-regression model predicts 5 year survival probabili-
ties in 1970 of around 72%, 58%, and 44% in patients aged
65, 70, and 7,5 respectively; in 2010 the meta-regression
model predicts 5 year survival probabilities of around88%, 81%, and 70% at these three patient ages,
respectively.DISCUSSION
Early survival after elective AAA repair has improved
dramatically over the last 50 years; the advent and rapid
uptake of EVAR has played a part, as have improved pre-
operative optimisation strategies, and peri- and post-
operative critical care management. This study, however,
demonstrates that there has been no measurable
improvement in the overall long-term survival of patients
undergoing elective infrarenal AAA repair, because
increasingly elderly cohorts have been treated over the time
period examined. After adjustment for the increasing age of
patients undergoing AAA repair, long-term survival
improved over time.
Five year survival after elective infrarenal AAA repair was
69% (67e71%). The pooled survival estimate reported is
identical to registry data reported from the Swedvasc pro-
spectively maintained registry covering the periods 1987e
2005.46 Although there was an improvement in age
adjusted survival, long-term mortality remains concerning
for this cohort despite improvements in cardiovascular risk
Table 4. Study characteristics.
First author or study name Study type
1 ¼ Admin Dataset
2 ¼ Prospective RCT
3 ¼ Cohort Study
4 ¼ Case Series
5 ¼ Registry
Study start Study mid-point Study end Median F/U Mean F/U Min F/U Max F/U
Bartoli 3 1998 2003 2007 e e e e
Bayazit 4 1990 1993 1996 e 34.5 2 87
Bernstein 3 1978 1982 1985 e e e e
Biancari 1 1979 1991 2002 54 e 19.2 103.2
Bos 5 1999 2003 2006 26.9 e e e
Boult 3 2002 2004 2008 e e e e
Brewster 1 1994 2000 2005 e e e e
Bryce 3 2005 2006 2007 e e e e
Cao 4 1997 2000 2003 e e e e
Conrad 1 1994 1996 1998 e 87 1 138
Coppi 3 1997 1999 2001 e e e e
De Bruin 2 2000 2002 2003 76.8 e 61.2 98.4
De Martino 1 2003 2007 2011 22.8 28.8 e e
Diehm 5 1994 2000 2006 e e e e
Egorova 1 1995 2001 2006 e e e e
Evans 4 1969 1977 1985 e 52 2 168
EVAR-1 2 1999 2002 2004 e e e e
EVAR-2 2 1999 2002 2004 e e e e
Hallett 1 1971 1979 1987 e e e e
Hinterseher 3 1995 2000 2005 e e e e
Koskas 1 1989 1992 1994 e e e e
Lederle e OVER 2 2002 2004 2008 e 62.4 e e
Lederle 2 1992 1997 2001 e 58.8 e e
Lifeline Registry 5 1998 2001 2004 e e e e
May 4 1992 1994 1996 e e e e
Mertens 5 1998 2001 2003 e e e e
Mukai 4 1974 1987 2000 e 66 2 254.4
Sahal 4 1995 2001 2006 e e e e
Steinmetz 5 1999 2003 2006 e e e e
Stonebridge 1 1980 1985 1989 e e e e
Taylor 1 1990 1994 1998 e e 60 e
UK SAT 2 1991 1993 1995 e 96 72 120
Verhoeven 3 2000 2004 2007 e 40 1 106
Wahlgren 5 2000 2003 2006 e e e e
Whittemore 4 1972 1975 1979 e e e e
Yasuhara 3 1980 1989 1997 e 30.2 e e
F/U ¼ follow up, in months.
Long-term Survival After AAA Repair 325prevention strategies, peri-operative and post-operative
management of aortic surgery, and vastly improved peri-
operative mortality rates, especially since the advent and
implementation of EVAR. A Western Australia study that
retrospectively reviewed long-term survival in survivors of
elective AAA surgery reported that 57.9% of deaths after 30
days in this patient group were attributable to cardiovas-
cular causes.9 Existing evidence demonstrates that patients
with AAA have at least a twofold increase in 5 year mor-
tality compared with matched controls, and that this in-
creases with aorta diameter despite surgical repair.47
Studies have also reported that patients with aneurysmal
aortas have an unusually pronounced burden of widespread
cardiovascular disease,9 and that patients with AAA sufferfrom signiﬁcant multisystem atherosclerosis, causing higher
rates of heart attacks, strokes, and major amputation.48
Where comorbidity was reported, the patients included
in this study had a characteristically high burden of multi-
system atherosclerosis. However, the relative paucity of
data to describe comorbidity also demonstrates the lack of
clear reporting standards and deﬁnitions in the existing
literature documenting long-term outcome for AAA repair.
Ischaemic heart disease was reported variously from “pre-
vious myocardial infarction” to “previous coronary artery
intervention” to “known ischaemic heart disease.” Similarly
the deﬁnition of abnormal lipids ranged from dyslipidaemia
to hypercholesterolemia. Reporting of concomitant pre-
ventative medication such as antiplatelet agents and statins
Table 5. Studies contributing to mean age analysis.
First author or study name Year of publication (study period) Number of patients Mean age (years)
Bartoli 2012 (1998e2007) 162 74.69
Bayazit 1999 (1990e1996) 167 64.01
Biancari 2003 (1979e2002) 358 67.30
Bos 2008 (1999e2006) 234 72.10
Boult 2007 (1999e2001) 961 75.00
Conrad 2007 (1994e1998) 540 73.00
De Bruin 2010 (2000e2003) 351 70.14
De Martino 2013 (2003e2011) 2367 72.16
Diehm 2007 (1994e2006) 711 75.80
Egorova 2011 (1995e2006) 84,640 75.73
EVAR-1 2010 (1999e2004) 1252 74.05
EVAR-2 2010 (1999e2004) 197 77.20
Hinterseher 2012 (1995e2005) 205 69.87
Lederle (OVER) 2012 (2002e2008) 881 70.05
Lederle 2002 (1992e2001) 569 68.40
Lifeline Registry 2005 (1998e2004) 2577 73.10
Mukai 2002 (1974e2000) 392 69.80
Steinmetz 2010 (1999e2006) 625 74.08
Stonebridge 1993 (1980e1989) 311 68.00
Taylor 2004 (1990e1998) 424 69.45
UK SAT 2002 (1991e1995) 563 69.30
Verhoeven 2011 (2000e2007) 365 74.00
Wahlgren 2008 (2000e2006) 3831 71.78
Yasuhara 1999 (1980e1997) 338 72.00
326 S.S. Bahia et al.was also very limited (Table 3), with little information on
dosage regimens or the particular details of individual drugs
that were used.
The link between larger aneurysm diameter and poorer
outcome has been described extensively in the past. The UK
Small Aneurysm Trial reported that baseline AAA diameter
was associated with increasing risks of non-aneurysm
related mortality and of cardiovascular mortality before/
after surgery; even after adjustment for other known risk
factors.40,49 The interaction between AAA diameter and
factors such as gender, age, smoking, hypertension, hyper-
cholesterolemia, and underlying genetic predisposition is
likely to play an important role for this association, but
remains incompletely understood.
Studies to modify cardiovascular risk in patients with
similar cardiovascular proﬁle to those with AAA have
demonstrated that multifactorial goal directed strategies
can signiﬁcantly reduce mid-term mortality.50 The same is
true for smoking cessation interventions, proactive pre-
scribing of risk modifying drugs, supervised exercise pro-
grammes, and the management of other contributory risk
factors such as hypertension. Focused research is required
to assess whether such efforts could modify long-term
survival in patients undergoing elective AAA repair and,
perhaps more importantly, whether patient selection needs
addressing to ensure only those likely to enjoy a survival
beneﬁt are offered intervention.Limitations of this work
This study was limited by the changes in clinical practice
over a long included timescale. Given the range of studiesanalysed, time period covered, and varied numbers of
contributing patients from each study, the pooled analysis
was associated with considerable statistical and methodo-
logical heterogeneity. The associations derived are obser-
vational rather than causal and should be interpreted with
caution. Meta-regression techniques are susceptible to ag-
gregation bias or ecological fallacy. In the absence of indi-
vidual patient data, associations identiﬁed from between-
study relationships should be interpreted with caution.
This study does not take into account potential variability of
life expectancy in the different countries that have
contributed to the overall analyses.
Further research
It is clear that focused research is needed to further
improve the long-term survival of patients undergoing
elective AAA repair. Most mortality for AAA patients is
attributable to cardiovascular disease. Goal directed medi-
cal therapy and behavioural interventions have a well
established role in patients surviving coronary intervention;
and require focused appraisal in patients with AAA.
Research should also address the objectivity of patient se-
lection, as it may be possible to identify a cohort with AAA
whose long-term survival is not modiﬁable regardless of
AAA repair.
CONCLUSION
Survivors of elective AAA repair continue to have poor life
expectancy despite surgery, although age adjusted survival
has improved. Focused research is needed to improve long-
term outcomes and case selection.
Figure 3. Survival probability (5 year) vs. study mid-date. The solid
curve shows the meta-regression model ﬁt, transformed to the
probability of survival scale. The dashed curves show point wise
conﬁdence intervals and the areas of the circles are inversely
proportional to the within study variances.
Figure 2. Pooled 5 year survival after elective IR AAA.
Figure 4. Survival probability (5 year) vs. study mean diameter. The
solid curve shows an unadjusted meta-regression model ﬁt,
transformed to the probability of survival scale. The dashed curves
show point wise conﬁdence intervals and the areas of the circles
are inversely proportional to the within study variances.
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Medline
1. MEDLINE; AORTIC ANEURYSM, ABDOMINAL/; 12672
results.
2. MEDLINE; (abdom* adj5 “aortic aneurysm*”).ti,ab;
11980 results.
3. MEDLINE; (“abdom* aort*” adj5 aneurysm*).ti,ab;
13277 results.
4. MEDLINE; AAA.ti,ab; 7955 results.
5. MEDLINE; 1 OR 2 OR 3 OR 4; 20771 results.
6. MEDLINE; (surger* OR surgical* OR repair*).ti,ab;
1326166 results.
7. MEDLINE; exp SURGICAL PROCEDURES, OPERATIVE/;
2260545 results.
8. MEDLINE; 6 OR 7; 2949023 results.
9. MEDLINE; 5 AND 8; 12080 results.
10. MEDLINE; SURVIVAL/; 3690 results.
11. MEDLINE; exp MORTALITY/OR SURVIVAL RATE/;
262329 results.
12. MEDLINE; DISEASE-FREE SURVIVAL/; 37912 results.
13. MEDLINE; (surviv* OR mortal*).ti,ab; 1005533 results.
14. MEDLINE; 10 OR 11 OR 12 OR 13; 1127177 results.
15. MEDLINE; 9 AND 14; 4098 results.
16. MEDLINE; SURGICAL PROCEDURES, ELECTIVE/; 7330
results.
17. MEDLINE; electiv*.ti,ab; 51612 results.
18. MEDLINE; (elect* OR choice* OR choos*).ti,ab;
1571983 results.
19. MEDLINE; ((non OR “not”) adj5 emergenc*).ti,ab; 5992
results.
20. MEDLINE; 16 OR 17 OR 18 OR 19; 1578904 results.
21. MEDLINE; 15 AND 20; 1473 results.
22. MEDLINE; 21 [Limit to: English Language]; 1286 results.
23. MEDLINE; 16 OR 17 OR 19; 59123 results.
24. MEDLINE; 15 AND 23; 1303 results.
25. MEDLINE; 24 [Limit to: English Language]; 1145 results.
Embase
1. abdominal aorta aneurysm/
2. (abdom* adj5 “aortic aneurysm*”).ti,ab.
3. (“abdom* aort*” adj5 aneurysm*).ti,ab.
4. AAA.ti,ab.5. 1 or 2 or 3 or 4
6. (surger* or surgical* or repair*).ti,ab.
7. surgery/or exp aorta surgery/or exp abdominal
surgery/or exp aneurysm surgery/
8. 6 or 7
9. (surviv* or mortal*).ti,ab.
10. survival/or disease free survival/or exp failure free
survival/or long term survival/or post treatment
survival/or survival rate/or survival time/
11. mortality/or surgical mortality/
12. 9 or 10 or 11
13. 5 and 8 and 12
14. (elect* or choice* or choos*).ti,ab.
15. ((non or “not”) adj5 emergenc*).ti,ab.
16. elective surgery/
17. 14 or 15 or 16
18. 13 and 17
19. limit 18 to english language
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